➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Boehringer Ingelheim
McKinsey
Mallinckrodt
McKesson

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: MESALAMINE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

MESALAMINE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Apil DELZICOL mesalamine CAPSULE, DELAYED RELEASE;ORAL 204412 NDA Allergan, Inc. 0023-5853-18 180 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0023-5853-18)
Apil DELZICOL mesalamine CAPSULE, DELAYED RELEASE;ORAL 204412 NDA A-S Medication Solutions 50090-3002-0 180 CAPSULE, DELAYED RELEASE in 1 BOTTLE (50090-3002-0)
Apil DELZICOL mesalamine CAPSULE, DELAYED RELEASE;ORAL 204412 NDA AUTHORIZED GENERIC Greenstone LLC 59762-0117-1 180 CAPSULE, DELAYED RELEASE in 1 BOTTLE (59762-0117-1)
Teva Pharms Usa MESALAMINE mesalamine CAPSULE, DELAYED RELEASE;ORAL 207873 ANDA Teva Pharmaceuticals USA, Inc. 0093-5907-86 180 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0093-5907-86)
Teva Pharms Usa MESALAMINE mesalamine CAPSULE, DELAYED RELEASE;ORAL 207873 ANDA AvKARE, Inc 42291-563-18 180 CAPSULE, DELAYED RELEASE in 1 BOTTLE (42291-563-18)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Moodys
Merck
Baxter
AstraZeneca